AHA: Stroke, VTE More Common with Darbepoetin - MedPage Today PDF Print
MedPage TodaySimilarly, there were no differences between the renal composite endpoint of death or end stage renal disease: 32.4% of patients on darbepoetin eversus ...Darbepoetin Alfa Risky for Type 2 Diabetics With Kidney Disease: Presented at AHA DG NewsAmerican Heart Association Late-breaking Clinical Trial Report: Risks of

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.